Solid Biosciences (SLDB)
6.41
-0.29 (4.33%)
Upcoming Events
Latest Headlines
Form 424B7 Solid Biosciences Inc.
June 5, 2026 4:04 PM - SEC Filing
Solid Biosciences (SLDB) PT Raised to $25 at H.C. Wainwright
June 3, 2026 6:49 AM - StreetInsider
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026 4:05 PM - StreetInsider
Solid Biosciences to Participate at Upcoming Investor Conferences
June 1, 2026 8:00 AM - StreetInsider
Solid Biosciences (SLDB) PT Lowered to $11 at JPMorgan
May 19, 2026 7:34 AM - StreetInsider
Solid Biosciences (SLDB) PT Lowered to $16 at Wedbush
May 13, 2026 8:31 AM - StreetInsider
Solid Biosciences (SLDB) PT Raised to $18 at Piper Sandler
May 13, 2026 7:22 AM - StreetInsider
Solid Biosciences (SLDB) Misses Q1 EPS by 52c
May 12, 2026 5:09 PM - StreetInsider
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
May 12, 2026 4:08 PM - Globe NewsWire
Form 10-Q Solid Biosciences Inc. For: Mar 31
May 12, 2026 4:03 PM - SEC Filing
Solid Biosciences begins phase 3 trial for Duchenne therapy SGT-003
May 7, 2026 8:00 AM - StreetInsider
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
May 7, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G/A Solid Biosciences Inc. Filed by: Invus Global Management, LLC
May 5, 2026 9:42 AM - SEC Filing
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026 4:05 PM - StreetInsider
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy
April 30, 2026 8:00 AM - Globe NewsWire
Solid Biosciences receives European orphan drug designation for SGT-003
April 28, 2026 8:02 AM - StreetInsider
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
April 28, 2026 8:01 AM - Globe NewsWire
Form SCHEDULE 13G/A Solid Biosciences Inc. Filed by: BlackRock, Inc.
April 27, 2026 4:14 PM - SEC Filing
Form ARS Solid Biosciences Inc. For: Dec 31
April 23, 2026 7:09 PM - SEC Filing
Form DEFA14A Solid Biosciences Inc.
April 23, 2026 7:09 PM - SEC Filing
Form DEF 14A Solid Biosciences Inc. For: Jun 10
April 23, 2026 7:08 PM - SEC Filing
Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Tan Kevin
April 21, 2026 4:06 PM - SEC Filing
Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Brooks Gabriel
April 21, 2026 4:06 PM - SEC Filing
Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Cumbo Alexander
April 21, 2026 4:06 PM - SEC Filing
Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Herzich Paul
April 21, 2026 4:06 PM - SEC Filing
Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Howton David T
April 21, 2026 4:06 PM - SEC Filing
Form 4 Solid Biosciences Inc. For: Jan 29 Filed by: Hanrahan Jessie
April 21, 2026 4:05 PM - SEC Filing
Form PRE 14A Solid Biosciences Inc. For: Jun 10
April 10, 2026 4:12 PM - SEC Filing
Form 8-K Solid Biosciences Inc. For: Apr 10
April 10, 2026 4:10 PM - SEC Filing
Solid Biosciences to Participate at Upcoming Investor Conferences
April 7, 2026 12:35 PM - Globe NewsWire
Solid Biosciences to Participate at Upcoming Investor Conferences
April 7, 2026 8:14 AM - StreetInsider
Form 4 Solid Biosciences Inc. For: Apr 02 Filed by: SMITH IAN F
April 2, 2026 4:06 PM - SEC Filing
Form EFFECT Solid Biosciences Inc.
April 1, 2026 6:07 AM - SEC Filing
Form EFFECT Solid Biosciences Inc.
April 1, 2026 6:07 AM - SEC Filing
Solid Biosciences (SLDB) PT Raised to $12 at JPMorgan
March 25, 2026 8:40 AM - StreetInsider
Guggenheim Starts Solid Biosciences (SLDB) at Buy
March 20, 2026 6:08 AM - StreetInsider
Form S-3 Solid Biosciences Inc.
March 19, 2026 5:05 PM - SEC Filing
Form S-3 Solid Biosciences Inc.
March 19, 2026 5:03 PM - SEC Filing
Solid Biosciences (SLDB) Tops Q4 EPS by 17c
March 19, 2026 4:58 PM - StreetInsider
Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 19, 2026 4:12 PM - Globe NewsWire
Form S-8 Solid Biosciences Inc.
March 19, 2026 4:11 PM - SEC Filing
Form 10-K Solid Biosciences Inc. For: Dec 31
March 19, 2026 4:02 PM - SEC Filing
Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
March 17, 2026 6:50 PM - SEC Filing
Citizens Reiterates Market Outperform Rating on Solid Biosciences (SLDB)
March 16, 2026 5:03 AM - StreetInsider
Truist Securities Reiterates Buy Rating on Solid Biosciences (SLDB): "we are buyers of the selloff"
March 12, 2026 8:41 AM - StreetInsider
Form 8-K Solid Biosciences Inc. For: Mar 11
March 12, 2026 6:01 AM - SEC Filing
Form 4 Solid Biosciences Inc. For: Mar 09 Filed by: EDELMAN JOSEPH
March 11, 2026 4:00 PM - SEC Filing
Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: PERCEPTIVE ADVISORS LLC
March 11, 2026 4:00 PM - SEC Filing
Solid Biosciences shares fall after gene therapy trial data
March 11, 2026 1:38 PM - StreetInsider
Solid Biosciences reports positive interim data from Duchenne gene therapy trial
March 11, 2026 1:01 PM - StreetInsider
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
March 11, 2026 1:01 PM - StreetInsider
Solid Biosciences (SLDB) halted, news pending
March 11, 2026 12:57 PM - StreetInsider
Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: BCLS SB Investco, LP
March 10, 2026 5:00 PM - SEC Filing
Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
March 10, 2026 4:39 PM - SEC Filing
Full Article List
